Objectives: To determine the prevalence and antimicrobial susceptibility of carbapenemase-producing Enterobacteriaceae among hospitalized patients and outpatients attending two military hospitals in Rawalpindi, Pakistan, and to compare the performance of two chromogenic culture media for the isolation of these organisms.
Introduction
The increasing incidence of infections caused by carbapenemase-producing Enterobacteriaceae should be a major worry to the international medical community. Of particular concern to many is the increasing occurrence of bacteria harbouring the NDM-1 enzyme. 1 Although first recorded only in 2008, NDM-1 was the predominant carbapenemase in Enterobacteriaceae in the UK in 2009, 2, 3 though not 2010, when KPC dominated. An increasing number of case reports and surveillance studies reveal a strong association between carriage of Enterobacteriaceae with the NDM-1 enzyme and prior hospitalization in and/or travel to the Indian subcontinent. 4 -6 Supporting this linkage, a recent report suggests that isolates producing the NDM-1 enzyme were disseminated in Indian healthcare facilities as early as 2006. Hospital and Combined Military Hospital in Rawalpindi, Pakistan, for faecal colonization. The second was to compare the performance of two chromogenic media designed for the isolation of carbapenemase-producing Enterobacteriaceae. The first medium was Colorex TM KPC (E&O Laboratories, Bonnybridge, UK), the only pre-prepared chromogenic medium for isolation of carbapenemase-producing Enterobacteriaceae presently marketed in the UK; the second was ID Carba (bioMérieux, La Balme-les-Grottes, France), a prototype chromogenic medium, based on chromID CPS, but with supplements to inhibit the growth of Gram-positive bacteria and non-carbapenemase producers.
Materials and methods

Materials
Colorex KPC agar plates were purchased from E&O Laboratories and ID Carba was provided by bioMérieux. The formulations of both media are proprietary and undisclosed. All other media were obtained from Thermofisher (Basingstoke, UK). The KPC and MBL Confirm ID and ESBL/ AmpC Screen kits (Rosco Diagnostica) were obtained from Bioconnections (Wetherby, UK); VITEK 2 cards, instrumentation and a Densimat were provided by bioMérieux. Instrumentation and consumables for matrixassisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) were obtained from Bruker (Coventry, UK). Dipicolinic acid, glucose-6-phosphate, fosfomycin and mecillinam were from Sigma (Poole, UK); other antimicrobials were obtained from their respective manufacturers.
Specimen collection and culture
Between 16 August and 29 September 2010, 200 stool samples were collected from separate individuals attending the Combined Military Hospital or the Military Hospital at Rawalpindi, Pakistan. These two hospitals have approximately 1000 and 800 beds, respectively. They primarily treat serving army personnel and their families, but civilian patients are also treated in both of the hospitals. The Combined Military Hospital has a range of specialized surgical units, including orthopaedics and plastic surgery, whereas the Military Hospital has most of the specialized medical units. Seventy of the stool samples were from hospitalized patients in seven distinct wards; 58 of these were from surgical units of the Combined Military Hospital and 12 were from three medical units in the Military Hospital. The remaining 130 were randomly selected from non-hospitalized individuals (both military and civilian) attending different outpatient departments of the Combined Military Hospital or reporting directly to the Armed Forces Institute of Pathology. All samples were obtained randomly and were not selected on the basis of suspected enteric infection or diarrhoea. All work was conducted in accordance with the Declaration of Helsinki and national and institutional standards. Consent for screening for carbapenemase-producing Enterobacteriaceae was obtained from all patients and their attending physicians.
Samples were anonymized and labelled with consecutive numbers that related only to hospital location. The samples were cultured on MacConkey agar at the Armed Forces Institute of Pathology, Rawalpindi, and incubated in air at 378C for 24 h. The mixed growth from MacConkey plates was then harvested using a swab and inoculated into glycerol broth for storage at 2608C for up to 4 weeks before transfer to the Freeman Hospital in a single shipment for further analysis. Immediately prior to shipment, the glycerol broths were thawed and 0.5 mL amounts were added to tubes containing 1.5 mL of Mueller-Hinton agar at 508C. Once the agar had solidified, the tubes were securely sealed.
Selective isolation and phenotypic detection of carbapenemase-producing Enterobacteriaceae A 500 mL aliquot of sterile water was added to each shipped tube, which was then re-sealed and vigorously mixed using a vortex mixer. Aliquots of 10 mL of liquid were then removed and cultured on cysteine lactose electrolyte deficient (CLED) medium and onto each of the two chromogenic agars. All media were incubated at 378C in air for 20 h. Growth on CLED medium was recorded, but colonies were not processed further. All distinct colony types recovered on either of the chromogenic media were investigated for evidence of carbapenemase activity using the KPC and MBL Confirm ID kits. These involved preparation of suspensions to the density of a 0.5 McFarland standard and inoculation of these onto Mueller-Hinton agar plates using a dipped swab. Discs containing 10 mg of meropenem alone or with various b-lactamase inhibitors (boronic acid, dipicolinic acid and cloxacillin) were placed on the agar surface and the plates were incubated overnight at 378C in air. Zone diameters were recorded, comparing those with and without inhibitor. A modified Hodge/cloverleaf test was also performed, as previously described, on all isolates using discs containing 10 mg of meropenem, imipenem and ertapenem. 8 All isolates recovered on either chromogenic medium were identified using both MALDI-TOF MS and VITEK 2.
Investigation of carbapenemase genes
Genes encoding IMP, VIM, GIM, SPM and SIM metallo-carbapenemases were sought by PCR from all the Gram-negative isolates recovered on either chromogenic medium, as previously described. 9 bla NDM was sought with primers NDM-For (5 ′ -GGG CAG TCG CTT CCA ACG GT-3 ′ ) and NDM-Rev (5 ′ -GTA GTG CTC AGT GTC GGC AT-3 ′ ), which amplify a 475 bp product. Cycling conditions were: 958C for 5 min; 30 cycles of 958C for 30 s, 608C for 40 s and 728C for 50 s; and 728C for 6 min. Selected amplicons were sequenced using an ABI 3730 DNA Analyzer (Applied Biosystems, Warrington, UK).
Susceptibility testing
All Gram-negative isolates recovered on either chromogenic medium were tested for susceptibility to a wide range of antimicrobials using the VITEK 2 system. MICs of meropenem, doripenem, fosfomycin and mecillinam were determined using a standard agar dilution methodology. 10 The inoculum used for MIC testing (10 4 cfu/spot) was also inoculated onto Colorex KPC and ID Carba agars. For fosfomycin only, 25 mg/L glucose-6-phosphate was incorporated into the Mueller-Hinton agar as recommended. 11 All plates were also inoculated with Pseudomonas aeruginosa NCTC 10662, Escherichia coli NCTC 10418 and Staphylococcus aureus NCTC 6571 as control strains.
Enterobacteriaceae were tested for the presence of extendedspectrum b-lactamases (ESBLs) and AmpC b-lactamases with the ESBL and AmpC Screen ID kits. Bacterial lawns were prepared as for susceptibility tests and were screened using discs containing cefotaxime alone and with various b-lactamase inhibitors (i.e. clavulanate, cloxacillin and clavulanate plus cloxacillin). Interpretation was in accordance with the manufacturer's instructions. This ESBL and AmpC assay was performed using MuellerHinton agar plates supplemented with 500 mg/L dipicolinic acid to neutralize the impact of metallo-carbapenemases.
Statistical analysis
Differences between the efficiencies of the two chromogenic media for isolation of carbapenemase-producing Enterobacteriaceae were Prevalence of NDM-1 in a Pakistan hospital compared using McNemar's test with the continuity correction applied. A x 2 test was used for comparison of prevalence in hospitalized and nonhospitalized individuals. Statistical significance was taken as P, 0.05.
Results
A total of 37 samples (18.5%) were found to contain Enterobacteriaceae that produced a carbapenemase. Nineteen positive samples were from inpatients (prevalence 27.1%), with colonized patients identified in six of the seven clinical areas sampled, including three surgical units of the Combined Military Hospital and three medical wards of the Military Hospital. In nonhospitalized individuals, prevalence was lower (P ¼ 0.02), and 18 positive samples were identified from 130 non-hospitalized patients (prevalence 13.8%).
In total, 64 isolates of carbapenemase-producing Enterobacteriaceae were recovered from these 37 samples (Table 1) , with E. coli (n¼ 30) the predominant species in both hospitalized and non-hospitalized populations, followed by Enterobacter cloacae (n¼ 21). Five other enterobacterial species were represented and three strains of Enterobacteriaceae that produced the NDM-1 enzyme could not be identified using MALDI-TOF MS or VITEK 2. These were subjected to complete sequencing of the 16S rRNA gene, and appear to belong to a putative new species of the Citrobacter genus (data not shown). Twenty patient samples contained two or more species of carbapenemase-producing Enterobacteriaceae. All the carbapenemase-producing Enterobacteriaceae isolates were found to produce the NDM-1 enzyme, as determined by PCR, with no other carbapenemases confirmed. In addition, NDM-1 was confirmed in three isolates of Acinetobacter baumannii and in one isolate of Aeromonas caviae. One isolate of Pseudomonas putida was confirmed by PCR to produce an IMP-type carbapenemase. No other carbapenemases were confirmed by PCR.
Synergy between meropenem and dipicolinic acid was 100% predictive for the presence of a metallo-carbapenemase, and discs containing this combination generated zone diameters at least 5 mm larger (mean 12 mm larger, range 5 -19 mm) than those containing the same amount of meropenem alone (10 mg); moreover the zones with meropenem plus dipicolinic acid were all ≥27 mm, indicating the absence of any non-metallo-carbapenemase. All 64 Enterobacteriaceae with NDM-1 carbapenemase gave a positive result in the modified Hodge test with all three carbapenems, though the reactions were often weak.
Ten isolates of Enterobacteriaceae grew on at least one of the chromogenic media, but did not harbour any carbapenemase gene detectable by PCR (Table 1) . These showed no synergy using the disc test with dipicolinic acid (zone diameter difference ≤2 mm), though four of them, all E. coli with ESBLs, did give a weak positive reaction in the modified Hodge test (data not shown). Table 1 compares the recovery of carbapenemase-producing Enterobacteriaceae (and other bacteria) on the two chromogenic media. Recovery was significantly better on ID Carba than on Colorex KPC (56/64 versus 41/64; P¼ 0.012), largely due to the failure to recover many carbapenemase-producing E. coli isolates on Colorex KPC. Thus 30 of 200 samples were found to contain carbapenemase-producing E. coli using ID Carba, but 18 of these were not recovered on Colorex KPC. Figure 1 shows a typical example of this problem. When these 30 isolates of E. coli were re-inoculated on Colorex KPC using a standardized MIC inoculum (approximately 10 4 cfu), 16 still failed to grow, and there was an absolute correspondence between inhibition when re-inoculated onto Colorex KPC and a meropenem MIC ≤2 mg/L, as determined by agar dilution. In contrast, all the isolates that were able to grow when subcultured on Colorex KPC exhibited MICs ≥4 mg/L. Four of 21 isolates of E. cloacae were isolated on Colorex KPC only, but grew on ID Carba when re-inoculated. For each of these four samples, two other species of NDM-1-producing Enterobacteriaceae were isolated on ID Carba. Only two isolates of carbapenemase-producing Enterobacteriaceae (both Providencia rettgeri) were inhibited when re-inoculated onto ID Carba. Despite the apparent limitations of Colorex KPC, only one additional patient was found to be colonized with carbapenemase-producing Enterobacteriaceae using ID Carba, with 37 positive specimens using ID Carba and 36 Perry et al.
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using Colorex KPC. This is because many of the E. coli isolates producing the NDM-1 enzyme that were not recovered by Colorex KPC were accompanied by other Enterobacteriaceae that also produced NDM-1 b-lactamase and which did grow on the medium. The respective sensitivity and specificity for detection of patients colonized by carbapenemase-producing Enterobacteriaceae were 100% and 93% for ID Carba and 97% and 96% for Colorex KPC.
When recovered on either medium (either on first isolation or after re-inoculation), E. coli always produced pink or red colonies, whereas other Enterobacteriaceae (except Morganella morganii) produced blue colonies on Colorex KPC or blue-green colonies on ID Carba, as did A. caviae. Non-fermenters and the single M. morganii produced colourless colonies. In all cases, generation of colour was unrelated to possession of resistance mechanisms.
ID Carba showed equivalent performance to Colorex KPC in terms of selectivity (see Table 1 ), although there were differences in the carbapenemase-negative isolates that were recovered. The three isolates of A. baumannii and one isolate of A. caviae that were found to produce NDM-1 were only recovered on Colorex KPC, however, all four isolates grew well on both media when re-inoculated as pure cultures. These four isolates were recovered from specimens also containing at least one species of carbapenemase-producing Enterobacteriaceae, suggesting that they may have been overgrown on ID Carba, although this cannot be proven.
Susceptibility of Enterobacteriaceae with NDM-1 enzyme
Susceptibility testing of the 64 isolates of Enterobacteriaceae harbouring NDM-1 enzyme was performed using VITEK 2 (bioMérieux), with interpretation using breakpoints (where available) set by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) 12 or, where not available, using those of the CLSI. 13 Other agents were tested by agar dilution, with 40 antimicrobials tested in total. As expected, there was widespread resistance to b-lactam agents, except mecillinam (see below), and none of the isolates was susceptible to ampicillin, amoxicillin/clavulanic acid, ampicillin/sulbactam, ticarcillin, ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam, cefalotin, cefuroxime, cefoxitin, cefixime, cefotaxime, ceftazidime, ceftriaxone or cefepime. All the isolates were non-susceptible to ertapenem and imipenem, with MICs ≥4 mg/L. Nevertheless, 53% of the E. coli isolates producing the NDM-1 enzyme were susceptible to meropenem when tested by agar dilution (47% when tested by VITEK 2), with similar MICs seen for doripenem. Phenotypic tests suggested ESBL production by 70% of isolates and AmpC production by 76%, with only two isolates (3%) producing neither of these enzymes. Co-production of ESBLs or AmpC provides an explanation for the high levels of aztreonam resistance seen in most isolates.
None of the isolates was susceptible to netilmicin and tobramycin. Susceptibility to other agents was variable, with colistin, mecillinam, fosfomycin and tigecycline the most active agents in vitro (see Table 2 ); most were also susceptible to nitrofurantoin, and minocycline MICs were commonly only 4 -8 mg/L, though it is unclear whether this indicates any useful clinical susceptibility. No pan-resistant isolates were found.
Discussion
This study has revealed a disturbing carriage rate of Enterobacteriaceae with NDM carbapenemase in both hospitalized (27.1%) and non-hospitalized patients (13.8%) in Rawalpindi, Pakistan. The gene for the NDM-1 enzyme was detected in 64 isolates of seven species of Enterobacteriaceae and in three isolates of A. baumannii and one of A. caviae. Strikingly, and in contrast to isolates with the NDM-1 enzyme from infections, the dominant producer species were E. coli and E. cloacae rather than Klebsiella pneumoniae. This was reflected in the higher susceptibility rates to fosfomycin, tigecycline and nitrofurantoin than in other recent studies where the NDM-1-positive isolates were dominated by Klebsiella spp., which are more often intermediate or resistant to these drugs. 3, 14 Kaleem et al. 15 reported the isolation of 39 metallo-b-lactamase producers from 2347 specimens collected at the Military Hospital in Rawalpindi during 2009. A. baumannii was predominant (n¼ 27), and the only species of Enterobacteriaceae that produced metallo-blactamase was E. coli (n ¼5).
The apparent activity of mecillinam against many of the present isolates is interesting, but should be treated with caution; whatever the effect of the NDM-1 enzyme on this drug, most of these isolates also had ESBLs, and these commonly confer inoculum-dependent resistance. 16 It is also striking that meropenem and doripenem MICs for many of the isolates were low, with many organisms technically susceptible at EUCAST breakpoints (Table 2 ). This suggests a greater detection challenge than previously perceived, as clinical isolates with the NDM-1 enzyme tend to be more clearly resistant.
It is essential that measures be put in place to at least decelerate the global spread of NDM-1 and other carbapenemases. Central to this is the development and widespread deployment of reliable screening methods. Chromogenic media have proven their utility for screening for antimicrobial-resistant pathogens, including methicillin-resistant S. aureus, glycopeptide-resistant enterococci and ESBL-producing Enterobacteriaceae. 17 -19 Colorex KPC is presently the only pre-prepared chromogenic medium for the detection of carbapenem-resistant Enterobacteriaceae commercially available in the UK, and its formulation is identical to that of CHROMagar KPC (D. Cameron, E&O Figure 1 . Pure growth of blue colonies of C. freundii with the NDM-1 enzyme on Colorex KPC medium (left). On ID Carba (right) the same specimen yields C. freundii as green colonies and E. coli as red colonies; both species produced NDM-1 carbapenemase.
Prevalence of NDM-1 in a Pakistan hospital 2291 JAC Table 2 . Susceptibility of Enterobacteriaceae with NDM-1 carbapenemase 21 evaluated CHROMagar KPC for the detection of carbapenemase-producing K. pneumoniae from rectal swabs from hospitalized patients in Athens, finding superior sensitivity to MacConkey agar supplemented with 1 mg/L imipenem; all these isolates carried bla VIM or bla KPC . Nordmann et al. 22 compared CHROMagar KPC with chromID ESBL for the ability to support the growth of 27 isolates with NDM-1 using a range of inocula. They found that chromID ESBL had superior sensitivity, and suggested that it might also be used to screen for faecal carriage of strains with the NDM-1 enzyme. The specificity of chromID ESBL for isolation of carbapenemase-producing Enterobacteriaceae from clinical samples is unproven, however, and may be limited in areas where Enterobacteriaceae that produce ESBLs and/or AmpC are widespread. This is crucial in India, for example, where 50% -70% of Enterobacteriaceae are reported to produce ESBLs. 23, 24 In this study, Colorex KPC failed to recover 23 isolates of Enterobacteriaceae with NDM carbapenemase that were recovered using ID Carba, whereas 8 showed the converse behaviour. Failure to recover a particular isolate may be due to the fact that (i) it is overgrown by a competitor, (ii) it is not differentiated adequately from neighbouring colonies of a different species that appear identical or (iii) it is inhibited by selective components of the culture medium. It was therefore instructive to re-inoculate all recovered isolates onto the test media. This experiment showed that 44 of 45 Enterobacteriaceae with NDM b-lactamase that were non-susceptible to meropenem (MIC .2 mg/L) grew well when re-inoculated onto Colorex KPC, whereas all 19 isolates of NDM-producing Enterobacteriaceae, including 16 E. coli, that were meropenem susceptible (MIC ≤2 mg/L) were inhibited. We can therefore conclude that Colorex KPC is unable to detect a significant subset of Enterobacteriaceae producing NDM-1 that demonstrate susceptibility to meropenem. ID Carba failed to recover eight isolates of NDM-1-producing Enterobacteriaceae that were recovered using Colorex KPC, however, only two of these (both P. rettgeri) failed to grow when re-inoculated onto ID Carba. Despite the better ability of ID Carba to isolate NDM-producing Enterobacteriaceae that were meropenem susceptible, both media showed an equivalent ability to inhibit Gram-negative bacteria that did not produce carbapenemase (Table 1) ; however, Colorex KPC was more effective at inhibiting carbapenemase-negative Enterobacteriaceae.
The modified Hodge test was shown to be highly sensitive for detection of carbapenemase, but lacked specificity. This test has been shown to be a useful screening tool for carbapenemases, but false positive results are not uncommon. 25 Diagnostic discs utilizing meropenem+dipicolinic acid were 100% predictive of the production of metallo-carbapenemase.
Some limitations to this study should be noted. First, we did not evaluate the chromogenic culture media with clinical samples and instead used organism suspensions derived from clinical samples. It is possible that a different inoculum from clinical samples might generate different results. This limitation is mitigated to some extent by the fact that both media were re-inoculated with pure isolates using controlled inocula. It is also possible that the transport of organism suspensions allowed for the horizontal transfer of bla NDM-1 between species within a single specimen. Neither of these factors diminishes the prevalence rate of positive individuals. Further studies are required using direct inoculation of clinical material onto test media.
